The line of evidences led us to investigate the serum levels of Gal-9 in the patients with type 2 diabetes and various stages of chronic kidney disease (CKD), since the alteration of serum Gal-9 levels may influence the status of immune responses and cell cycle regulation in the various cells including kidney cells. This evidence concerns the gene LGALS9 and type 2 diabetes mellitus.